Genome guided investigation of bioactive metabolites isolated from Lacticaseibacillus rhamnosus BIONCL3 strain and their biological activities
Food Bioscience · 2026-11 · 85 · 109969
DOI: 10.1016/j.fbio.2026.109969 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Bioscience, 2026-11. Verfasst von Bharat Pande und 8 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Gefördert von: CSIR-National Chemical Laboratory.
Abstract (Originalsprache)
In this study, a novel probiotic Lacticaseibacillus rhamnosus BIONCL3 strain was isolated from indigenous Gir-cow milk, Maharashtra, India. Comprehensive phenotypic and genotypic profiling confirmed its probiotic efficacy highlighting BIONCL3 as a promising candidate for functional food applications. Whole genome sequencing (WGS) of the strain was categorized into 22 COG groups, established genetic safety confirming absence of AMR genes, plasmids, virulence factor, and pathogenic genes. Moreover, antiSMASH identified key bacteriocin, BGC including Garvieacin Q (garQ), Carnocin CP52, enterocin-X-chain-beta, and gutSMASH analyses pathways for thiamine metabolism and short-chain fatty acids production, along with 104 CAZyme, dominated by glycoside hydrolases (GH) and glycosyltransferases (GT). Chemical profiling of BIONCL3 strain capable to biosynthesize four bioactive metabolites, indole-3-propionic acid (IPA), succinic acid (SA), benzoic acid (BA), and bis(( R )-2-ethylhexyl) phthalate (DEHP). The structure elucidation of these metabolites were characterized through extensive 1D NMR ( 1 H and 13 C{ 1 H}) and 2D NMR (HSQC, HMBC, and NOESY) analysis. In silico studies showed excellent binding affinities of biofilm-associated proteins, with binding energies of −7.3 kcal/mol with Als9-2 (2Y7L), −7.3 kcal/mol for OprF (4RLC), and −7.6 kcal/mol for FapC (9NQD). Phenotypic screening proved SA as the most potent inhibitor against Staphylococcus aureus NCIM 2925 (MIC 31.6 μg/mL; IC 50 of 30.60 μg/mL), followed by IPA ( MIC, 82.00 μg/mL). In vitro assays with synergistic binary, tertiary and quaternary combination exhibited the excellent antimicrobial efficacy (ΣFIC< 0.5), resulting 95 to 98% of bacterial membrane integrity (7.6 to 8.2 μg/mL). Further, sub-MIC levels exerted substantial antibiofilm and membrane-perturbing effects against Pseudomonas aeruginosa NCIM2700 (95.65%) and Candida albicans NCIM3628 (88%), highlight the BIONCL3 as a candidate for functional foods and biomedical interventions.
Förderung
- CSIR-National Chemical Laboratory
Zitieren
APA
Pande, B., Mahajan, V., Bhosale, S., Shimpi, S., Vinodkumar, R., Yadav, P., Dharne, M., Kontham, R., & Vamkudoth, K. R. (2026). Genome guided investigation of bioactive metabolites isolated from Lacticaseibacillus rhamnosus BIONCL3 strain and their biological activities. Food Bioscience, 85, 109969. https://doi.org/10.1016/j.fbio.2026.109969
Vancouver
Pande B, Mahajan V, Bhosale S, Shimpi S, Vinodkumar R, Yadav P, et al. Genome guided investigation of bioactive metabolites isolated from Lacticaseibacillus rhamnosus BIONCL3 strain and their biological activities. Food Bioscience. 2026;85:109969. doi:10.1016/j.fbio.2026.109969
BibTeX
@article{Pande2026,
author = {Pande, Bharat and Mahajan, Vaishnavi and Bhosale, Shivam and Shimpi, Sagar and Vinodkumar, Ramavath and Yadav, Pranay and Dharne, Mahesh and Kontham, Ravindar and Vamkudoth, Koteswara Rao},
title = {Genome guided investigation of bioactive metabolites isolated from Lacticaseibacillus rhamnosus BIONCL3 strain and their biological activities},
journal = {Food Bioscience},
year = {2026},
volume = {85},
pages = {109969},
doi = {10.1016/j.fbio.2026.109969}
}
EUVIMED